Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Rose 10.6% in First Half of 2023

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 56.8 million yuan in the first half of 2023, up 10.6% year-on-year.

Meanwhile, the company posted 609 million yuan in revenue, up 31.9% year-on-year.

At the end of the reporting period, it had 2.6 billion yuan in total assets and 831.9 million yuan in total liabilities, with a liability-to-asset ratio of 32%.